AM-01: Introduction to the program
John Q. Trojanowski
page S89
Full Text | Full-Text PDF (82 KB)

AM-03: Do selective inhibitors discern the relative roles of kinases in the regulation of tau phosphorylation?
Joel B. Schachter, Lit- Fui Lau, Karl E.G. Richter, Charles E. Nolan, James M. Cook
page S89
Full Text | Full-Text PDF (82 KB)

AM-05: Cholesterol modulators: Overview
Sam Gandy
page S89
Full Text | Full-Text PDF (84 KB)

AM-07: Anti-inflammation agents and anti-oxidants - overview
Greg M. Cole
page S90
Full Text | Full-Text PDF (46 KB)

AM-09: Caloric restriction
Mark P. Mattson
pages S90-S91
Full Text | Full-Text PDF (58 KB)

AM-11: Enriched environments
Orly Lazarov
page S91
Full Text | Full-Text PDF (49 KB)

IM-01: 3D and 4D MR imaging of aging and dementia: Principles and pitfalls
Paul Thompson
page S92
Full Text | Full-Text PDF (100 KB)

IM-03: Mr imaging at 3.0T: Advantages and drawbacks
Matt Bernstein
page S92
Full Text | Full-Text PDF (100 KB)

IM-05: Multi-site MRI studies: Problems and principles
Derek L. Hill
page S93
Full Text | Full-Text PDF (44 KB)

IM-07: Genetic mechanisms of memory
Daniel Weinberger
page S93
Full Text | Full-Text PDF (44 KB)

IM-09: Advantages of MRI
Stefan J. Teipel, Christine Born, Harald Hampel
pages S93-S94
Full Text | Full-Text PDF (52 KB)

IM-11: Advantages of fMRI
Reisa Sperling
page S94
Full Text | Full-Text PDF (43 KB)

IM-13: Pros and cons of groups analysis
Richard Frackowiak
page S94
Full Text | Full-Text PDF (43 KB)

P-001: Alzheimer’s disease patient’s dependency on unpaid caregivers: Activities and impacts
H. Michael Arrighi, Trent McLaughlin, Christopher Leibman
page S95
Full Text | Full-Text PDF (46 KB)

P-003: An eight minute time limit increases sensitivity and improves clinical utility of the folstein mini mental state exam in african americans
Angela V. Ashley, Felicia C. Goldstein, James J. Lah, Jonathan M. Flacker, Allan I. Levey
pages S95-S96
Full Text | Full-Text PDF (58 KB)

P-005: Utility of brief cognitive screening measures for detection of cognitive impairment in three ethnic groups
Ranjan Duara, Silvia Strauman, Warren W. Barker, Lidia Perrotta, David Loewenstein
page S96
Full Text | Full-Text PDF (50 KB)

P-007: The main cardiovascular diseases and pathogenic subtypes causing ischemic stroke in mongolian elderly
Oyunkh Raghcaa, Baasanjav Damchaa, Soyolmaa Puntsag, Solongo Munkhtogoo
page S97
Full Text | Full-Text PDF (48 KB)

P-009: T cell-based vaccination of AD-transgenic mice induces plaque clearance, hippocampal neurogenesis and improves learning and memory abilities: A key role of microglial activation that express IGF-I
Maya Koronyo, Oleg Butovsky, Gilad Kunis, Eran Ophir, Gennady Landa, Hagit Cohen, Michal Schwartz
pages S97-S98
Full Text | Full-Text PDF (60 KB)

P-011: A novel vitamin/nutraceutical formulation that delays cognitive decline and improves mood in early-stage Alzheimer’s disease
Amy Chan, James Paskavitz, Thomas B. Shea
page S98
Full Text | Full-Text PDF (51 KB)

P-013: Effect of geto combination on production and degradation of aβ in the brain of APPV717i transgenic mice
Jinzhou Tian, Jing Shi, Yi XU, Junxiang Yin, Shuli Sheng, Yongyan Wang
page S99
Full Text | Full-Text PDF (50 KB)

P-015: A responder analysis of MPC-7869 (tarenflurbil), a selective Aβ42-lowering agent, in mild Alzheimer’s disease (AD): Analysis from a phase 2 study of up to 24 months of treatment
Kenton H. Zavitz, Suzanne Hendrix, Mark Laughlin, Edward Swabb
pages S99-S100
Full Text | Full-Text PDF (61 KB)

P-017: How much risk is an Alzheimer’s disease patient willing to take to treat their Alzheimer’s disease?
Jason Karlawish, Jonathan Rubright
page S100
Full Text | Full-Text PDF (47 KB)

P-019: Serum copper in Alzheimer’s disease
Rachna Aggarwal, Suman Kushwaha
pages S101-S102
Full Text | Full-Text PDF (58 KB)

P-021: Spatial patterns in CBF depression in Alzheimer’s disease from multivariate analysis of continuous arterial spin labeling MRI
Truman R. Brown, Christian Habeck, Ajna Borogovac, Nikolaos Scarmeas, Yaakov Stern, Iris Asllani
page S102
Full Text | Full-Text PDF (49 KB)

P-023: Arterial spin-labeling MR imaging in middle-aged adults at risk for Alzheimer’s disease: Association of clinical measures of global vascular risk with quantitative cerebral perfusion
Cynthia M. Carlsson, Guofan Xu, Zhifei Wen, Howard A. Rowley, David C. Alsop, Karl K. Vigen, Alan B. McMillan, Zachary J. Clark, Rachel D. McKinsey, John M. Ollinger, Mark A. Sager, Sanjay Asthana, Sean B. Fain, Sterling C. Johnson
page S103
Full Text | Full-Text PDF (504 KB)

P-025: MRI atrophy in mci is specific, not sensitive, for progression to Alzheimer disease
Howard M. Chertkow, Christina Wolfson, Jose Correa, Susan Murtha, David Wolfson, Roger McKelvey, Louis Verret, Victor Whitehead
page S104
Full Text | Full-Text PDF (50 KB)

P-027: CSF transthyretin levels are associated with APOE genotype and CSF aβ42 in AD
Suzanne Craft, Elaine Peskind, Dmitry Goldgaber, Gail Li, Wei Nie, Douglas Galasko, James Leverenz, Eric Petrie, Murray Raskind
pages S104-S105
Full Text | Full-Text PDF (134 KB)

P-029: Correlation of regional in VIVO pittsburgh compound-B (PIB) retention with in vitro PIB, Aβ levels, and amyloid plaque density: Validation of PIB-PET in postmortem human brain
Steven Trent DeKosky, Chet A. Mathis, Julie C. Price, Milos D. Ikonomovic, Ronald L. Hamilton, Eric E. Abrahamson, Willam R. Paljug, Manik L. Debnath, Caroline E. Hope, Barbara A. Isanski, Nikolaos D. Tsopelas, Brian J. Lopresti, Scott Ziolko, Wehzu Bi, William E. Klunk
page S105
Full Text | Full-Text PDF (125 KB)

P-031: Medial orbitofrontal cortex hyperperfusion in young onset Alzheimer’s disease
Terri A. Edwards-Lee, Julia Chung, Atul Munjal, Frederick Mishkin, Panukorn Vasinrapee
page S106
Full Text | Full-Text PDF (474 KB)

P-033: Preliminary cross-sectional and longitudinal volumetric analyses of MRI data from the Alzheimer’s disease neuroimaging initiative (ADNI) using morphometry birn methods
Christine Fennema-Notestine, Donald J. Hagler, Adam S. Fleisher, Elaine H. Wu, David S. Karow, Linda K. McEvoy, Anders M. Dale
page S107
Full Text | Full-Text PDF (48 KB)